358
The U.S. Food and Drug Administration (FDA) has issued a safety communication advising against the use of smartwatches or smart rings that claim to measure blood glucose levels without piercing the skin. This warning is directed at consumers, patients, caregivers, and healthcare providers, emphasizing that the FDA has not authorized, cleared, or approved any such devices for this purpose. The alert distinguishes these products from smartwatch applications that display data from FDA-authorized devices, such as continuous glucose monitoring devices (CGMs), which do require skin piercing. The...
426
As the opioid crisis continues to devastate communities across the United States, digital health services have emerged as a beacon of hope for increasing access to essential addiction treatment and recovery support. However, the promise of these digital platforms is marred by significant privacy and security concerns that threaten the very fabric of effective addiction healthcare.
The...